Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions
Tuberculosis Testing Capabilities

State-of-the-art technologies, quality management systems, and high-quality infrastructure to...

Laboratory Expertise for Early Bactericidal Activity (EBA) Studies

Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or...

Q2 Solutions vaccine lab services play major part in establishing efficacy in trial for influenza...

Zika Vaccine Research: Complex Steps Toward a Critical Need

Overcoming Zika vaccine development challenges

Q2 Solutions Anti-infective and Vaccine Development Services

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

A CRO lab perspective on Ebola vaccine development

Vaccines in the Fight against Malaria

What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow?

A Super Battle Against Superbugs: Developing an Effective Drug-Resistant...

Assays to drive success in anti-infective and vaccine development

Extensive expertise for vaccine assay development and diagnostics

Combating Emerging and Re-Emerging Infectious Diseases in Clinical Trials...